Model behavior has been tested on a variety of conditions: muscle cells with Pten KO or with induced insulin resistance, knockdown and overexpression of PRAS, TSC2-null cells, cells treated with rapamycin and anticancer drugs such as AZD8055 and UCN-01. This evidence concerns the gene PTEN and Insulin resistance.